Validity and Reliability of the US National Cancer Institute’s Patient-Reported Outcomes Version of the Common Terminology Criteria for Adverse Events (PRO-CTCAE)-Reference-Cited by-同舟云学术

Validity and Reliability of the US National Cancer Institute’s Patient-Reported Outcomes Version of the Common Terminology Criteria for Adverse Events (PRO-CTCAE)

Published:2015-11-01 Issue:8 Volume:1 Page:1051
ISSN:2374-2437
Container-title:JAMA Oncology
language:en
Short-container-title:JAMA Oncol

Author:

Dueck Amylou C.¹,Mendoza Tito R.²,Mitchell Sandra A.³,Reeve Bryce B.⁴,Castro Kathleen M.³,Rogak Lauren J.⁵,Atkinson Thomas M.⁶,Bennett Antonia V.⁴,Denicoff Andrea M.⁷,O'Mara Ann M.⁸,Li Yuelin⁶,Clauser Steven B.³,Bryant Donna M.⁹,Bearden James D.¹⁰,Gillis Theresa A.¹¹,Harness Jay K.¹²,Siegel Robert D.¹³,Paul Diane B.¹⁴,Cleeland Charles S.²,Schrag Deborah¹⁵,Sloan Jeff A.¹⁶,Abernethy Amy P.¹⁷,Bruner Deborah W.¹⁸,Minasian Lori M.⁷,Basch Ethan¹⁹

Affiliation:

1. Department of Health Sciences Research, Mayo Clinic, Scottsdale, Arizona

2. Department of Symptom Research, University of Texas MD Anderson Cancer Center, Houston

3. Division of Cancer Control and Population Sciences, National Cancer Institute, Rockville, Maryland

4. Lineberger Comprehensive Cancer Center, University of North Carolina, Chapel Hill

5. Department of Epidemiology and Biostatistics, Memorial Sloan Kettering Cancer Center, New York, New York

6. Department of Psychiatry and Behavioral Sciences, Memorial Sloan Kettering Cancer Center, New York, New York

7. Division of Cancer Treatment and Diagnosis, National Cancer Institute, Rockville, Maryland

8. Division of Cancer Prevention, National Cancer Institute, Rockville, Maryland

9. Department of Clinical Research, Cancer Program of Our Lady of the Lake and Mary Bird Perkins, Baton Rouge, Louisiana

10. Gibbs Cancer Center and Research Institute, Spartanburg, South Carolina

11. Helen F. Graham Cancer Center and Research Institute, Christiana Care Health System, Newark, Delaware

12. Center for Cancer Prevention and Treatment, St. Joseph Hospital of Orange, Orange, California

13. Helen and Harry Gray Cancer Center, Hartford Hospital, Hartford, Connecticut

14. patient advocate and cancer survivor, Brooklyn, New York

15. Division of Population Sciences, Dana-Farber Cancer Institute, Boston, Massachusetts

16. Department of Health Sciences Research, Mayo Clinic, Rochester, Minnesota

17. Department of Medicine, Duke University Medical Center, Durham, North Carolina

18. Nell Hodgson Woodruff School of Nursing, Emory University, Atlanta, Georgia

19. Lineberger Comprehensive Cancer Center, University of North Carolina, Chapel Hill5Department of Epidemiology and Biostatistics, Memorial Sloan Kettering Cancer Center, New York, New York

Publisher

American Medical Association (AMA)

Subject

Oncology,Cancer Research

Cited by 599 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Efficacy, safety, and prognostic modeling in neoadjuvant immunotherapy for esophageal squamous cell carcinoma;International Immunopharmacology;2024-12

2. Psychometric properties of patient-reported outcomes Common Terminology Criteria for adverse events (PRO-CTCAE®) in breast cancer patients: The prospective observational multicenter VIP study;The Breast;2024-10

3. Efficacy on symptoms and mortality day vs. night administration of EGFR-TKIs for advanced non-small cell lung cancer;Supportive Care in Cancer;2024-09-09

4. Validation of Patient-Reported Outcomes in Patients With Nonmetastatic Breast Cancer Receiving Comprehensive Nodal Irradiation in the RadComp Trial;International Journal of Radiation Oncology*Biology*Physics;2024-09

5. Stereotactic Magnetic Resonance–Guided Daily Adaptive Radiation Therapy for Localized Prostate Cancer: Acute and Late Patient-Reported Toxicity Outcomes;Advances in Radiation Oncology;2024-09